Examination of Postoperative Changes in Lipid Profile and Glycemic Markers After Coronary Artery Bypass Graft, Percutaneous Intervention Vs Aortic Valve Replacement Demonstrated a Shift in Risk Factors for Coronary Artery Disease
Kelley Flesher,Amal Mathew,Yuliya Borovskiy,Krzysztof Laudanski
DOI: https://doi.org/10.2147/jmdh.s470819
2024-10-01
Journal of Multidisciplinary Healthcare
Abstract:Kelley Flesher, 1 Amal Mathew, 2 Yuliya Borovskiy, 3, 4 Krzysztof Laudanski 5 1 Department of Neurology, Division of Neurocritical Care, University of Pennsylvania, Philadelphia, PA, USA; 2 School of Biomedical Engineering, Science and Health Systems, Drexel University, Philadelphia, PA, USA; 3 Corporate Informational Service, Penn Medicine, Philadelphia, PA, USA; 4 Data Analytics Core, Penn Medicine, Philadelphia, PA, USA; 5 Department of Anesthesiology and Perioperative Care, Mayo Clinic, Rochester, MN, USA Correspondence: Krzysztof Laudanski, Department of Anesthesiology and Perioperative Care, Division of Critical Care Medicine, Mayo Clinic, 200 1st St, Rochester, MN, 55902, USA, Tel +1 (507) 255-5123, Email Purpose: Surgery-related stress may affect the metabolome, leading to abnormal lipid profiles and ineffective glycemic control. Here, we gauge these changes as they may accelerate atherosclerosis, limiting the benefits of interventions aimed at improving coronary artery disease (CAD) progression. Patients and Methods: Electronic medical records were queried to identify patients undergoing coronary artery bypass grafting (CABG), percutaneous coronary intervention (PCI), or aortic valve replacement (AVR). 7573 records denoted lipid profile (cholesterol, LDL, HDL, VLDL, triglycerides) and glucose metabolism impairment (HbA1c). Pre-procedure lipid and glucose laboratory values were compared with periods representing acute periprocedural inflammation (1– 3 months), resolution of acute inflammation (3– 6 months), convalescence (6– 12 months), and medium- (1– 2 years), and long-term periods (2– 5 years). Results: Baseline values differed between groups (AVR: Cholesterol↑↓, LDL↓↑, HDL↓, Triglycerides↑, HbA1c↓; CABG: Cholesterol↓, LDL↓, HDL↓, Triglycerides↓, HbA1c↓; PCI: Cholesterol↑↓, LDL↑↓, HDL↑↓, Triglycerides↓, HbA1c↓). Interestingly, total cholesterol and LDL had opposite trajectories after CABG vs AVR even five years after surgical procedure and the effects were moderate as denoted by d -Cohen statistics. HDL declined acutely after CABG and AVR but not after PCI. Triglycerides were elevated for 2 years after AVR but depressed after CABG and PCI. HbA1c remained depressed for up to 5 years after any studied procedure. Conclusion: Our data suggest surgical procedures result in prolonged lipid profile and glycemic metabolism disturbances, particularly after aortic valve replacement, indicating more aggressive post-surgical treatment of these metabolic abnormalities may be warranted. Keywords: cardiac surgery, inflammation, lipid profile, glycated hemoglobin Despite advances in care, coronary artery disease (CAD) continues to comprise nearly 20% of mortality in the United States and worldwide. 1 Atherosclerosis is recognized as the main etiopathogenic factor, with dysfunctional cholesterol and impaired glucose metabolism playing synergistic roles. 2 Interestingly, perioperative inflammation profoundly affects the metabolome, but its scope and duration are unknown despite the theoretical impact on the progression of atherosclerosis, thus limiting the long-term benefits of surgery. 2–10 Progression of CAD necessitates the performance of percutaneous intervention (PCI) or coronary artery bypass grafting (CABG) in symptomatic patients. 4,11 CABG-related surgery is inevitably associated with inflammation, thus affecting lipid profile and glucose metabolism. 7,12,13 PCI may also affect inflammation but less than surgical procedures. 14 These differences in perioperative inflammation on changes in lipid profile and glucose metabolism will depend on the duration, magnitude, and nature of the postoperative changes of CAD risk factors. For example, hypocholesterolemia accompanying acute post-surgical inflammation may either retard or accelerate disease progression, depending on whether a post-procedural drop in either LDL or HDL is more profound. 15–17 Postoperative impairment in glucose supports CAD progression. 4,5 In some cases, postoperative variation of VLDL and lipoprotein A remained unexplored despite their effect on atherosclerosis and variation of their level during critical stress. 18,19 On the other hand, increased frequency of pharmacological interventions aimed at atherosclerosis risk reduction is often part of procedural or surgical intervention and may counteract the postoperative increase in risk factors. 16 The complex effect of surgery on lipid and glucose metabolism may explain some of the unexpected outcomes offered by a recent trial comparing PCI vs CABG in diabetic patients. 20 This complex inte -Abstract Truncated-
health care sciences & services